Inactive Instrument

Highlights Mirati Therapeutics

Equities

MRTX

US60468T1051

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

British billionaire Joe Lewis intends to plead guilty to US charges, lawyer says	Jan. 24	RE
Bristol-Myers Squibb Closes Acquisition of Mirati Therapeutics	Jan. 23	MT
Bristol-Myers Squibb Closes Mirati Therapeutics Acquisition	Jan. 23	MT
Bristol Myers: acquisition of Mirati Therapeutics finalized	Jan. 23	CF
Bristol-Myers Squibb Company completed the acquisition of Mirati Therapeutics, Inc. from a group of shareholders.	Jan. 22	CI
Mirati Therapeutics' Krazati Lung Cancer Treatment Gets EU Conditional Marketing Authorization	Jan. 10	MT
Bristol Myers expects to launch 16 new products through 2030 - CEO	Jan. 08	RE
US FDA turns down Amgen lung cancer drug Lumakras for full approval	Dec. 26	RE
Bristol-Myers Agrees Deal to Buy RayzeBio for About $4.1 Billion	Dec. 26	MT
Bristol-Myers Squibb Strikes $14 Billion Deal to Acquire Karuna Therapeutics	Dec. 22	MT
Mirati Therapeutics, Inc. Receives Positive Opinion from CHMP for KRAZATI as a Targeted Treatment Option for Patients with Advanced Non-Small Cell Lung Cancer with a KRASG12C Mutation Following a Re-Examination Procedure	Nov. 10	CI
Earnings Flash (MRTX) MIRATI THERAPEUTICS Posts Q3 Revenue $16.4M	Nov. 06	MT
Mirati Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 06	CI
Kura Oncology, Mirati Therapeutics Launch Collaboration, Supply Deal to Assess KO-2806, Adagrasib to Treat Lung Cancer	Nov. 02	MT
Kura Oncology, Inc. and Mirati Therapeutics, Inc. Enter into Clinical Collaboration and Supply Agreement to Evaluate KO-2806 and Adagrasib in KRASG12C-Mutated NSCLC	Nov. 02	CI
Bristol Myers says it needs another year to hit target for new drugs	23-10-26	RE
Mirati Therapeutics, Inc. Presents Late-Breaking Results Evaluating the Combination of Adagrasib and Pembrolizumab in First-Line Non-Small Cell Lung Cancer	23-10-17	CI
Global markets live: Boeing, Amgen, Microsoft, Volkswagen, Tesla...	23-10-09
Trending : Bristol Myers Squibb Buying Mirati Therapeutics	23-10-09	DJ
Mirati Shares Slip Premarket on Bristol Myers Takeover	23-10-09	DJ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Mirati Therapeutics

Equities

MRTX

US60468T1051

Highlights

Filters